The grant from Innovate UK is matched by recent seed backing from LifeArc, Parkwalk and UKI2S.
"Bringing validation of our novel gene therapy and the opportunity to accelerate the development of our pipeline, we are delighted to receive this grant from Innovate UK. Ikarovec believes its approach has great potential in the treatment of the debilitating disease of wet AMD, with significant advantages over existing therapies and those in development."
The mental health platform secured backing from the government agency to advance its technology and expand its team.
"We’re incredibly honoured and proud to have received this grant. Most of the funds will be used towards further development and content for the app as we have high expectations to deliver a platform that is contextually smart as well as impactful with practical, actionable steps and content."
The Phase II grant from SBRI Healthcare will fund pre-clinical safety and efficacy studies for regenerative cartilage treatments.
"We select projects strategically based on both commercial and scientific considerations and are delighted with the progress of this collaboration with Dr. Wael Kafienah’s laboratory at the University of Bristol. The continued support for our lead musculoskeletal asset from SBRI Healthcare has not only allowed us to reach this phase but will enable us to carry the chondrocyte conversions through to the next stage."
Scottish Enterprise has awarded the funding to support regional growth and job creation at the healthtech firm.
"As we look to further scale the business in the months and years ahead, the support from Scottish Enterprise will enable us to grow the team to keep apace with our strategic growth plans. We are building a fantastic team at Care Sourcer and we’re excited at the prospect of even more talented people joining the fold as we look to fix the broken care system in this country."